OTC Markets EXMKT - Delayed Quote USD
Solanbridge Group, Inc. (SLNX)
0.0000
0.0000
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Breakdown
TTM
Operating Expense
174.6350
Operating Income
-174.6350
Net Non Operating Interest Income Expense
-127.1860
Pretax Income
-301.8210
Net Income Common Stockholders
-301.8210
Diluted NI Available to Com Stockholders
-301.8210
Basic EPS
-0.03
Diluted EPS
-0.03
Basic Average Shares
12,296.5730
Diluted Average Shares
15,460.0800
Total Operating Income as Reported
-174.6350
Total Expenses
174.6350
Net Income from Continuing & Discontinued Operation
-301.8210
Normalized Income
-301.8210
Interest Expense
127.1860
Net Interest Income
-127.1860
EBIT
-174.6350
EBITDA
-174.6350
Net Income from Continuing Operation Net Minority Interest
-301.8210
Normalized EBITDA
-174.6350
1/7/57287 - 6/29/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NWPN The Now Corporation
0.0001
0.00%
GSAC GelStat Corp.
0.0004
+33.33%
GCAN The Greater Cannabis Company, Inc.
0.0010
0.00%
CRNO-B.ST Cereno Scientific AB (publ)
8.00
+0.38%
CBDL CBD Life Sciences Inc.
0.0004
+33.33%
CPHI China Pharma Holdings, Inc.
1.8700
+13.43%
SXTC China SXT Pharmaceuticals, Inc.
2.2900
+44.94%
RDHL RedHill Biopharma Ltd.
2.4100
+3.88%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3100
+4.52%
UPC Universe Pharmaceuticals INC
4.2000
+10.53%